Neuren Pharmaceuticals: Half Yearly Report and Accounts 30 June 2015
Filed with ASX · · 14 pages · English
Neuren Pharmaceuticals Limited (“Neuren” or the “Company”) presents this financial report, including the interim consolidated financial statements, for the six months ended 30 June 2015, with the six months ended 30 June 2014 as the comparative period. 2. Results for announcement to the market 2.6 Explanation of results: The consolidated net loss after tax increased from $4.7 million to $5.3 milli
Neuren Pharmaceuticals Limited on 6ix
In the deck
Follow Neuren Pharmaceuticals into a list and get an email when it puts out news.
Follow Neuren Pharmaceuticals